Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways

AUTOR(ES)

Arbiser, Jack L.

FONTE

The National Academy of Sciences of the USA

RESUMO

The switch from a quiescent tumor to an invasive tumor is accompanied by the acquisition of angiogenic properties. This phenotypic change likely requires a change in the balance of angiogenic stimulators and angiogenic inhibitors. The nature of the angiogenic switch is not known. Here, we show that introduction of activated H-ras into immortalized endothelial cells is capable of activating the angiogenic switch. Angiogenic switching is accompanied by up-regulation of vascular endothelial growth factor and matrix metalloproteinase (MMP) bioactivity and down-regulation of tissue inhibitor of MMP. Furthermore, we show that inhibition of phosphatidylinositol-3-kinase leads to partial inhibition of tumor angiogenesis, thus demonstrating that activated H-ras activates tumor angiogenesis through two distinct pathways. Finally, we show evidence for two forms of tumor dormancy.

Documentos Relacionados

• The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.
• Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters.
• Reversible abrogation of IL-3 dependence by an inducible H-ras oncogene.
• H-Ras Signaling and K-Ras Signaling Are Differentially Dependent on Endocytosis
• Mutants of H-ras that interfere with RAS effector function in Saccharomyces cerevisiae.